This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

NEWS

All developments in the becoming of Eurofins Amatsigroup's future

Manufacturing Chemist Pharma - Propanc signs contract manufacturing agreement with AmatsiQBiologicals

"Australian cancer drug developer Propanc Health Group has signed a contract manufacturing agreement with Belgian firm AmatsiQBiologicals. AmatsiQBiologicals will develop and manufacture under GMP (Good Manufacturing Practice) some of Propanc's enz…
Read more

(FR) Chimie Pharma Hebdo - Amatsigroup : «Notre objectif est d’atteindre 50M€ de chiffre d’affaires en 2018»

Sorry, this entry is only available in French.
Read more

(FR) BiotechFinances - AmatsiGroup s'implante dans le "vet corridor" aux Etats-Unis

Sorry, this entry is only available in French.
Read more

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please call me at
your phone number
or send an e-mail to
your e-mail address
and
leave your message.